David Alan Campbell
Chief Executive Officer at Janux Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Janux Therapeutics Inc., 3 years.
Chief executive roles
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 31, 2026 | Janux Therapeutics Inc. | Gift | โ123,840 | โ | โ |
| Jul 8, 2026 | Janux Therapeutics Inc. | Option exercise | +7,000 | $4.21 | $29,470 |
| Jan 2, 2026 | Janux Therapeutics Inc. | Open-market sale | โ8,072 | $13.73 | $110,829 |
| Jan 2, 2026 | Janux Therapeutics Inc. | Grant or award | +96,600 | โ | โ |
| Jan 7, 2025 | Janux Therapeutics Inc. | Open-market sale | โ5,000 | $60.00 | $300,000 |
| Jan 2, 2025 | Janux Therapeutics Inc. | Grant or award | +81,000 | โ | โ |
| Dec 24, 2024 | Janux Therapeutics Inc. | Open-market sale | โ25,000 | $56.19 | $1,404,750 |
| Dec 3, 2024 | Janux Therapeutics Inc. | Open-market sale | โ15,000 | $67.00 | $1,005,000 |
| Nov 25, 2024 | Janux Therapeutics Inc. | Open-market sale | โ18,281 | $51.43 | $940,192 |
| Nov 25, 2024 | Janux Therapeutics Inc. | Open-market sale | โ6,719 | $52.04 | $349,657 |
| Oct 28, 2024 | Janux Therapeutics Inc. | Open-market sale | โ13,897 | $53.22 | $739,598 |
| Oct 28, 2024 | Janux Therapeutics Inc. | Open-market sale | โ11,103 | $53.94 | $598,896 |
| Sep 27, 2024 | Janux Therapeutics Inc. | Open-market sale | โ18,957 | $46.09 | $873,728 |
| Sep 27, 2024 | Janux Therapeutics Inc. | Open-market sale | โ5,248 | $46.86 | $245,921 |
| Sep 27, 2024 | Janux Therapeutics Inc. | Open-market sale | โ795 | $47.84 | $38,033 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.